Trust and Transparency Rule: How Scientists Choose Antibodies in 2025

SAN FRANCISCO, Oct. 13, 2025 /PRNewswire/ -- Biocompare, the leading resource used by millions of life scientists worldwide to find the right lab product or service for their research, has just released its latest Antibody Market Report. Drawing on feedback from hundreds of scientists, the 2025 report highlights evolving trends in antibody selection, purchasing behavior, and usage.

A key finding is that reproducibility, validation, and specificity of RUO antibodies remain top priorities for both academic and commercial researchers. This emphasis on reliability is likely driving a continued shift toward recombinant antibody purchases, reflecting users' increasing demand for consistent performance and quality control.

Researchers are also placing greater weight on vendor trust, with the 2025 survey showing stronger preference for purchasing from well-established, reputable suppliers. Familiarity with a vendor's brand and product transparency now carry more influence than it did just three years ago when Biocompare released its 2022 Antibody Report.

The report also found that search behavior across the community is evolving with many scientists beginning their antibody research using Google rather than vendor websites. This finding points to the growing importance of online visibility and digital presence in reaching antibody customers.

The report also identifies top vendors across multiple categories, including best antibody specificity, antibody reproducibility, customer service, overall website experience, packaging, quality of technical data presented on website, target selection, and technical support. Survey respondents also identified their top vendors for over antibody categories (e.g., cell signaling/signal transduction, apoptosis/tumor suppressor, cytokines/chemokines, etc.).

These rankings as well as trends and insights across antibody selection, purchasing, and usage are all included in the Biocompare's 2025 Antibody Market Report. For more information about the report, email [email protected].

SOURCE BioCompare